SCHEMBL5392425

SCHEMBL5392425

COC(=O)c1[nH]c2ccc(C)cc2c1C=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.55
HSD17B10 Q99714 9/20 0.55
GAA P10253 4/20 0.55
TSHR P16473 3/20 0.55
HTT P42858 3/20 0.55
GFER P55789 2/20 0.55
KDM4E B2RXH2 11/20 0.54
MAPT P10636 7/20 0.53
KMT2A Q03164 6/20 0.52
SMN1; SMN2 Q16637 6/20 0.52
HPGD P15428 6/20 0.52
MEN1 O00255 5/20 0.52
ALOX15 P16050 2/20 0.50
NR4A2 P43354 1/20 0.50
NPC1 O15118 1/20 0.49
TP53 P04637 1/20 0.49
RAB9A P51151 1/20 0.49
MAPK1 P28482 3/20 0.48
NPSR1 Q6W5P4 1/20 0.45
USP2 O75604 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25207025 0.89 ALOX15 (0.57) ALDH1A1HSD17B10GAATSHRHTT
SCHEMBL5399472 0.86 ALDH1A1 (0.67) ALDH1A1HSD17B10GAATSHRHTT
SCHEMBL5402454 0.84 ALOX15 (0.60) ALDH1A1HSD17B10GAATSHRKDM4E
SCHEMBL22346709 0.84 KMT2A (0.54) ALDH1A1GAATSHRHTTKDM4E
SCHEMBL15329883 0.84 TUBB4A (0.57) ALDH1A1HSD17B10GAATSHRHTT
SCHEMBL29951480 0.84 KMT2A (0.56) ALDH1A1HSD17B10GAATSHRHTT
SCHEMBL29953042 0.84 ALOX15 (0.60) ALDH1A1HSD17B10GAATSHRKDM4E
SCHEMBL29954951 0.84 MEN1 (0.58) ALDH1A1HSD17B10GAAHTTGFER
SCHEMBL15331015 0.82 PTGS1 (0.50) ALDH1A1HSD17B10GAATSHRHTT
SCHEMBL2800262 0.81 KDM4E (0.57) ALDH1A1HSD17B10GAAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-7217729-B2 Substituted indoles, process for the production thereof and use thereof for combatting pain GRUNENTHAL GMBH (DE) 2007-05-15 US disclosed
US-20040225003-A1 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies GRUNENTHAL GMBH (DE) 2004-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040225003-A1 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies HNMT, HTR6, HTR3C ALDH1A1 1253/4885HSD17B10 2171/4885GAA 1007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.